Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880565 · ClinicalTrials.gov registry record · NA
Advanced Reperfusion Strategies for Refractory Cardiac Arrest
A NA study, sponsored by University of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03880565 is a NA study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 30 participants.
The verdict
NCT03880565, a NA study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a Phase II, single center (Under the Center for Resuscitation Medicine at the University of Minnesota Medical School), partially blinded, prospective, intention to treat, safety and efficacy clinical trial, randomizing adult patients (18-75 years old) with refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/VT) out-of hospital cardiac arrest (OHCA) who are transferred by emergency medical services (EMS) with ongoing mechanical cardiopulmonary resuscitation (CPR) or who are resuscitated to receive one of the 2 local standards of care practiced in our community: 1) Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation or 2) Standard Advanced Cardiac Life Support (ACLS) Resuscitation
Interventions
- DEVICE Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation
- DEVICE Standard Advanced Cardiac Life Support (ACLS) Resuscitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-08-09 |
| Est. Completion | 2020-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03880565
The ClinicalTrials.gov registry entry for NCT03880565 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation is the first listed.
NCT03880565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03880565 about?
NCT03880565 is a clinical study titled "Advanced Reperfusion Strategies for Refractory Cardiac Arrest". This is a Phase II, single center (Under the Center for Resuscitation Medicine at the University of Minnesota Medical School), partially blinded, prospective, intention to treat, safety and efficacy clinical trial, randomizing adult patients (18-75 years old) with refractory ventricular fibrillation...
What is the current status of trial NCT03880565?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2019-08-09. Estimated completion is 2020-10-09.
What interventions are being tested in trial NCT03880565?
The interventions under investigation include: Early Extracorporeal Membrane Oxygenation (ECMO) Facilitated Resuscitation (DEVICE), Standard Advanced Cardiac Life Support (ACLS) Resuscitation (DEVICE).
Who is sponsoring clinical trial NCT03880565?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.